225 related articles for article (PubMed ID: 12078239)
41. Ferriprotoporphyrin IX: role in chloroquine susceptibility and resistance in malaria.
Fitch CD
Prog Clin Biol Res; 1989; 313():45-52. PubMed ID: 2675116
[TBL] [Abstract][Full Text] [Related]
42. [Antimalarial action of alloxan and 5,6-diamino-2,4-dihydroxy-pyrimidine in Plasmodium berghei].
Huang ZY; Chang HL; Wu KY; Wang JJ
Zhongguo Yao Li Xue Bao; 1989 Mar; 10(2):181-4. PubMed ID: 2683580
[TBL] [Abstract][Full Text] [Related]
43. Uptake of a fluorescently tagged chloroquine analogue is reduced in CQ-resistant compared to CQ-sensitive Plasmodium falciparum parasites.
Reiling SJ; Rohrbach P
Malar J; 2019 Oct; 18(1):342. PubMed ID: 31590674
[TBL] [Abstract][Full Text] [Related]
44. [Differences in haemozoin production and pathogenicity between chloroquine-sensitive and chloroquine-resistant strains of Plasmodium berghei].
Yan J; Song G; Gong Z; Lu Y
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(1):16-20. PubMed ID: 12563809
[TBL] [Abstract][Full Text] [Related]
45. Reversal of chloroquine resistance with verapamil in P. berghei in vivo.
Valecha N; Biswas S; Dewan S; Bhambhani S
Indian J Malariol; 1992 Mar; 29(1):47-53. PubMed ID: 1459299
[TBL] [Abstract][Full Text] [Related]
46. Chloroquine resistance in malaria: accessibility of drug receptors to mefloquine.
Fitch CD; Chan RL; Chevli R
Antimicrob Agents Chemother; 1979 Feb; 15(2):258-62. PubMed ID: 371544
[TBL] [Abstract][Full Text] [Related]
47. Polyamine metabolism in various tissues during pathogenesis of chloroquine-susceptible and resistant malaria.
Mishra M; Chandra S; Pandey VC; Tekwani BL
Cell Biochem Funct; 1997 Dec; 15(4):229-35. PubMed ID: 9415968
[TBL] [Abstract][Full Text] [Related]
48. [Maturation of dendritic cells and activation of B-lymphocytes in spleens of ICR mice infected with chloroquine-resistant Plasmodium berghei].
Chen KQ; Zhu HM; Ni CR; Song GH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Feb; 26(1):1-5. PubMed ID: 18637575
[TBL] [Abstract][Full Text] [Related]
49. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
Friebolin W; Jannack B; Wenzel N; Furrer J; Oeser T; Sanchez CP; Lanzer M; Yardley V; Becker K; Davioud-Charvet E
J Med Chem; 2008 Mar; 51(5):1260-77. PubMed ID: 18260613
[TBL] [Abstract][Full Text] [Related]
50. Nucleus may be the key site of chloroquine antimalarial action and resistance development.
Li GD
Med Hypotheses; 2006; 67(2):323-6. PubMed ID: 16549276
[TBL] [Abstract][Full Text] [Related]
51. [Action of chloroquine on glutathione metabolism in erythrocytes parasitized by Plasmodium berghei].
Bhatia A; Charet P
Ann Parasitol Hum Comp; 1984; 59(3):317-20. PubMed ID: 6380377
[TBL] [Abstract][Full Text] [Related]
52. Plasmodium falciparum chloroquine resistance marker protein (Pfcrmp) may be a chloroquine target protein in nucleus.
Li GD
Med Hypotheses; 2007; 68(2):332-4. PubMed ID: 16997492
[TBL] [Abstract][Full Text] [Related]
53. Implications of Glutathione Levels in the Plasmodium berghei Response to Chloroquine and Artemisinin.
Vega-Rodríguez J; Pastrana-Mena R; Crespo-Lladó KN; Ortiz JG; Ferrer-Rodríguez I; Serrano AE
PLoS One; 2015; 10(5):e0128212. PubMed ID: 26010448
[TBL] [Abstract][Full Text] [Related]
54. Chloroquine resistance of Plasmodium berghei: biochemical basis and countermeasures.
Salganik RI; Pankova TG; Chekhonadskikh TV; Igonina TM
Bull World Health Organ; 1987; 65(3):381-6. PubMed ID: 3117393
[TBL] [Abstract][Full Text] [Related]
55. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
56. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.
Ojurongbe O; Ogungbamigbe TO; Fagbenro-Beyioku AF; Fendel R; Kremsner PG; Kun JF
Malar J; 2007 Apr; 6():41. PubMed ID: 17428334
[TBL] [Abstract][Full Text] [Related]
57. Combination effects of chloroquine with the febrifugine and isofebrifugine mixture against a blood-induced infection with chloroquine-resistant Plasmodium berghei NK65 in ICR mice.
Ishih A; Suzuki T; Watanabe M; Miyase T; Terada M
Phytother Res; 2003 Dec; 17(10):1234-6. PubMed ID: 14669265
[TBL] [Abstract][Full Text] [Related]
58. In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum.
Maerki S; Brun R; Charman SA; Dorn A; Matile H; Wittlin S
J Antimicrob Chemother; 2006 Jul; 58(1):52-8. PubMed ID: 16735432
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.
Mohapatra PK; Prakash A; Taison K; Negmu K; Gohain AC; Namchoom NS; Wange D; Bhattacharyya DR; Goswami BK; Borgohain BK; Mahanta J
Trop Med Int Health; 2005 May; 10(5):478-83. PubMed ID: 15860095
[TBL] [Abstract][Full Text] [Related]
60. Plasmodium chabaudi: association of reversal of chloroquine resistance with increased accumulation of chloroquine in resistant parasites.
Miki A; Tanabe K; Nakayama T; Kiryon C; Ohsawa K
Exp Parasitol; 1992 Mar; 74(2):134-42. PubMed ID: 1740175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
